Product

CST-2032

Aliases

CST-2032, matching placebo for CST-2032, CST-107, matching placebo for CST-107

1 clinical trial

2 indications

Indication

Mild Cognitive Impairment

Indication

Clinical trial

A Phase 2a, Randomized, Placebo-Controlled, Double-Blind, Crossover Study to Evaluate the Effects of CST-2032 and CST-107 on Cognition in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Parkinson's or Alzheimer's Disease

Status: Completed, Estimated PCD: 2023-12-01